Pulmonx Corporation (NASDAQ: LUNG) reported Q1 EPS of ($0.36), $0.07 better than the analyst estimate of ($0.43). Revenue for the quarter came in at $18.9 million versus the consensus estimate of $17.79 million.

GUIDANCE:

Pulmonx Corporation sees Q2 2024 revenue of $81-84 million, versus the consensus of $82.18 million.

For earnings history and earnings-related data on Pulmonx Corporation (LUNG) click here.